Works by Rha, Sun-Young

Results: 114
    1

    Phase I and pharmacokinetic study of cisplatin and troxacitabine administered intravenously every 28 days in patients with advanced solid malignancies.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 167, doi. 10.1007/s00280-009-1020-y
    By:
    • Chia-Chi Lin;
    • Beeram, Muralidhar;
    • Rowinsky, Eric K.;
    • Takimoto, Chris H.;
    • Ng, Chee M.;
    • Geyer Jr., Charles E.;
    • Denis, Louis J.;
    • De Bono, Johann S.;
    • Hao, Desiree;
    • Tolcher, Anthony W.;
    • Rha, Sun-Young;
    • Jolivet, Jacques;
    • Patnaik, Amita
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9

    Relationship between p53 Overexpression and Gastric Cancer Progression.

    Published in:
    Oncology, 1997, v. 54, n. 2, p. 166, doi. 10.1159/000227682
    By:
    • Kim, Joo-Hang;
    • Uhm, Hyo Dong;
    • Gong, Soo Jung;
    • Shin, Dong Hwan;
    • Choi, Jin Hyuk;
    • Lee, Hye Ran;
    • Noh, Sung Hoon;
    • Kim, Byung Soo;
    • Cho, Jae Yong;
    • Rha, Sun Young;
    • Yoo, Nae Choon;
    • Chung, Hyun Cheol;
    • Roh, Jae Kyung;
    • Min, Jin Sik;
    • Lee, Kyong Sik
    Publication type:
    Article
    10

    Overexpression of c-ErbB-2 Protein in Gastric Cancer by Immunohistochemical Stain.

    Published in:
    Oncology, 1996, v. 53, n. 3, p. 192, doi. 10.1159/000227559
    By:
    • Lee, Hye Ran;
    • Kim, Joo-Hang;
    • Uhm, Hyo Dong;
    • Ahn, Joong Bae;
    • Rha, Sun Young;
    • Cho, Jae Yong;
    • Lee, Jong In;
    • Lee, Kyong Hee;
    • Chung, Hyun Cheol;
    • Roh, Jae Kyong;
    • Min, Jin Sik;
    • Lee, Kyong Sik;
    • Shin, Dong Hwan;
    • Kim, Byung Soo;
    • Hong, Soon Won;
    • Choi, Jin-Hyuk
    Publication type:
    Article
    11
    12
    13
    14
    15
    16

    Kidney Cancer Working Group Report.

    Published in:
    Japanese Journal of Clinical Oncology, 2010, v. 40, n. suppl_1, p. i51, doi. 10.1093/jjco/hyq127
    By:
    • Naito, Seiji;
    • Tomita, Yoshihiko;
    • Rha, Sun Young;
    • Uemura, Hirotsugu;
    • Oya, Mototsugu;
    • Song, He Zhi;
    • Zhong, Li Han;
    • Wahid, Mohamed Ibrahim Bin A
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24

    First-Line Tislelizumab Plus Chemotherapy for Advanced Gastric Cancer with Programmed Death-Ligand 1 Expression ≥ 1%: A Retrospective Analysis of RATIONALE-305.

    Published in:
    Advances in Therapy, 2025, v. 42, n. 5, p. 2248, doi. 10.1007/s12325-025-03133-7
    By:
    • Moehler, Markus;
    • Oh, Do-Youn;
    • Kato, Ken;
    • Arkenau, Tobias;
    • Tabernero, Josep;
    • Lee, Keun-Wook;
    • Rha, Sun Young;
    • Hirano, Hidekazu;
    • Spigel, David;
    • Yamaguchi, Kensei;
    • Wyrwicz, Lucjan;
    • Disel, Umut;
    • Pazo-Cid, Roberto A.;
    • Fornaro, Lorenzo;
    • Xu, Yaling;
    • Sheng, Tao;
    • Yang, Silu;
    • Kadva, Alysha;
    • Cruz-Correa, Marcia;
    • Xu, Rui-Hua
    Publication type:
    Article
    25
    26

    A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy.

    Published in:
    Investigational New Drugs, 2012, v. 30, n. 2, p. 672, doi. 10.1007/s10637-010-9625-x
    By:
    • Shin, Sang Joon;
    • Ahn, Joong Bae;
    • Park, Kyung Soo;
    • Lee, Yoon Jung;
    • Hong, Yong Sang;
    • Kim, Tae Won;
    • Kim, Hye Ryun;
    • Rha, Sun Young;
    • Roh, Jae Kyung;
    • Kim, Dal-Hyun;
    • Kim, Chin;
    • Chung, Hyun Cheol
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33
    34
    35

    Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study (KCSG-ST19-16).

    Published in:
    Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211042812
    By:
    • Han, Hye Sook;
    • Kim, Bum Jun;
    • Jee, Hee-Jung;
    • Ryu, Min-Hee;
    • Park, Se Hoon;
    • Rha, Sun Young;
    • Kim, Jong Gwang;
    • Bae, Woo Kyun;
    • Lee, Keun-Wook;
    • Oh, Do-Youn;
    • Kim, In-Ho;
    • Sym, Sun Jin;
    • Oh, So Yeon;
    • Kim, Hyeong Su;
    • Byun, Ji-Hye;
    • Kim, Dong Sook;
    • Suh, Young Ju;
    • An, Hyonggin;
    • Zang, Dae Young
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42
    43

    Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study (KCSG-ST19-16).

    Published in:
    Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211042812
    By:
    • Han, Hye Sook;
    • Kim, Bum Jun;
    • Jee, Hee-Jung;
    • Ryu, Min-Hee;
    • Park, Se Hoon;
    • Rha, Sun Young;
    • Kim, Jong Gwang;
    • Bae, Woo Kyun;
    • Lee, Keun-Wook;
    • Oh, Do-Youn;
    • Kim, In-Ho;
    • Sym, Sun Jin;
    • Oh, So Yeon;
    • Kim, Hyeong Su;
    • Byun, Ji-Hye;
    • Kim, Dong Sook;
    • Suh, Young Ju;
    • An, Hyonggin;
    • Zang, Dae Young
    Publication type:
    Article
    44

    EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group.

    Published in:
    2019
    By:
    • Wagner, Anna Dorothea;
    • Grabsch, Heike I.;
    • Mauer, Murielle;
    • Marreaud, Sandrine;
    • Caballero, Carmela;
    • Thuss-Patience, Peter;
    • Mueller, Lothar;
    • Elme, Annelie;
    • Moehler, Markus Hermann;
    • Martens, Uwe;
    • Kang, Yoon-Koo;
    • Rha, Sun Young;
    • Cats, Annemieke;
    • Tokunaga, Masanori;
    • Lordick, Florian
    Publication type:
    journal article
    45

    Efficacy and safety of lenvatinib plus pembrolizumab vs sunitinib in the East Asian subset of patients with advanced renal cell carcinoma from the CLEAR trial.

    Published in:
    International Journal of Cancer, 2023, v. 153, n. 6, p. 1241, doi. 10.1002/ijc.34608
    By:
    • Rha, Sun Young;
    • Choueiri, Toni K.;
    • Matveev, Vsevolod B.;
    • Alyasova, Anna;
    • Hong, Sung‐Hoo;
    • Gordoa, Teresa Alonso;
    • Gurney, Howard;
    • Bjarnason, Georg A.;
    • Buchler, Tomas;
    • Pedrazzoli, Paolo;
    • Takagi, Toshio;
    • Park, Se Hoon;
    • Lee, Jae Lyun;
    • Perini, Rodolfo F.;
    • He, Cixin S.;
    • McKenzie, Jodi A.;
    • Eto, Masatoshi
    Publication type:
    Article
    46
    47

    Risk factors and model for predicting toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.

    Published in:
    2016
    By:
    • Kaymakcalan, Marina D.;
    • Xie, Wanling;
    • Albiges, Laurence;
    • North, Scott A.;
    • Kollmannsberger, Christian K.;
    • Smoragiewicz, Martin;
    • Kroeger, Nils;
    • Wells, J. Connor;
    • Rha, Sun‐Young;
    • Lee, Jae Lyun;
    • McKay, Rana R.;
    • Fay, André P.;
    • De Velasco, Guillermo;
    • Heng, Daniel Y. C.;
    • Choueiri, Toni K.
    Publication type:
    journal article
    48

    Metastatic non-clear cell renal cell carcinoma treated with targeted therapy agents: Characterization of survival outcome and application of the International mRCC Database Consortium criteria.

    Published in:
    Cancer (0008543X), 2013, v. 119, n. 16, p. 2999, doi. 10.1002/cncr.28151
    By:
    • Kroeger, Nils;
    • Xie, Wanling;
    • Lee, Jae‐Lyn;
    • Bjarnason, Georg A.;
    • Knox, Jennifer J.;
    • MacKenzie, Mary J.;
    • Wood, Lori;
    • Srinivas, Sandy;
    • Vaishamayan, Ulka N.;
    • Rha, Sun‐Young;
    • Pal, Sumanta K.;
    • Yuasa, Takeshi;
    • Donskov, Frede;
    • Agarwal, Neeraj;
    • Kollmannsberger, Christian K.;
    • Tan, Min‐Han;
    • North, Scott A.;
    • Rini, Brian I.;
    • Choueiri, Toni K.;
    • Heng, Daniel Y.C.
    Publication type:
    Article
    49
    50